Upsher-Smith launches generic Absorica
The isotretinoin capsule had a market value of approximately $156 million for the 12 months ended April 2021, according to IQVIA.
Upsher-Smith is offering isotretinoin capsules, a generic of Sun Pharmaceuticals’ Absorica.
It is used in patients aged 12 years old and older for the treatment of severe nodular acne that cannot be cleared up by any other acne treatments, including antibiotics.
The isotretinoin capsule had a market value of approximately $156 million for the 12 months ended April 2021, according to IQVIA.